Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells

Clemente‑Soto,Aldo  F.; Salas‑Vidal,Enrique; Milan‑Pacheco,Cesar; Sánchez‑Carranza,Jessica   Nayelli; Peralta‑Zaragoza,Oscar; González‑Maya,Leticia

doi:10.3892/mmr.2019.9850

Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells

Authors:
- Aldo F. Clemente‑Soto
- Enrique Salas‑Vidal
- Cesar Milan‑Pacheco
- Jessica Nayelli Sánchez‑Carranza
- Oscar Peralta‑Zaragoza
- Leticia González‑Maya
View Affiliations

Affiliations: Faculty of Pharmacy, Autonomous University of Morelos State (UAEM), Cuernavaca, Morelos CP 62209, México, Department of Developmental Genetics and Molecular Physiology, National Autonomous University of Mexico, Cuernavaca, Morelos, CP 62210, México, Direction of Chronic Infections and Cancer, Research Center in Infection Diseases, National Institute of Public Health, Cuernavaca, Morelos, CP 62100, México
Published online on: January 11, 2019 https://doi.org/10.3892/mmr.2019.9850
Pages: 2097-2106
Copyright: © Clemente‑Soto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cervical cancer is the second most common cancer in women worldwide. Human papillomavirus (HPV) infection appears to be a necessary factor in the development of almost all cases (>95%) of cervical cancer. HPV E6 induces a change of control of p53 stabilization from Hdm2 to E6/E6AP in HPV‑infected cells. It is well known that the LxxLL motif of cellular ubiquitin ligase E6AP binds to the pocket of E6 and causes a conformational change to enable E6 to bind p53 competently. In the ternary complex E6/E6AP/p53, p53 is polyubiquitinated by E6AP and subsequently degraded by a proteasome. Therefore, these cells are deficient in the processes regulated by p53, including apoptosis, damaged DNA repair, and the cell cycle. In the present study, it was demonstrated that quercetin induced G2 phase cell cycle arrest and apoptosis in both HeLa and SiHa cells, accompanied by an increase of p53 and its nuclear signal. It was also observed that quercetin increased the level of the p21 transcript and the pro‑apoptotic Bax protein, which are two p53‑downstream effectors. However, quercetin did not alter the expression of the HPV E6 protein in cervical cancer cells; therefore, the increase in p53 occurred in an E6 expression‑independent manner. Furthermore, molecular docking demonstrated that quercetin binds stably in the central pocket of E6, the binding site of E6AP. These data suggest that quercetin increases the nuclear localization of p53 by interrupting E6/E6AP complex formation in cervical cancer cells.

View Figures

View References

1	Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A and Colombo N; ESMO Guidelines Committee, : Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 28 Suppl_4:iv72–iv83. 2017. View Article : Google Scholar : PubMed/NCBI
2	Dürst M, Gissmann L, Ikenberg H and zur Hausen H: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA. 80:3812–3815. 1983. View Article : Google Scholar : PubMed/NCBI
3	Gardiol D, Kühne C, Glaunsinger B, Lee SS, Javier R and Banks L: Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene. 18:5487–5496. 1999. View Article : Google Scholar : PubMed/NCBI
4	Nakagawa S and Huibregtse J: Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol. 20:8244–8253. 2000. View Article : Google Scholar : PubMed/NCBI
5	Ansari T, Brimer N and Vande Pol SB: Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53. J Virol. 86:11386–11391. 2012. View Article : Google Scholar : PubMed/NCBI
6	Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Vande Pol S, Podjarny A, et al: Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature. 529:541–545. 2016. View Article : Google Scholar : PubMed/NCBI
7	Scheffner M, Huibregtse JM, Vierstra RD and Howley PM: The HPV-16 E6 and E6-AP complex functions as an ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:495–505. 1993. View Article : Google Scholar : PubMed/NCBI
8	Huibregtse JM, Scheffner M and Howley PM: A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:4129–4135. 1991. View Article : Google Scholar : PubMed/NCBI
9	Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton RA and McDougall JK: Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc Natl Acad Sci USA. 88:570–574. 1991. View Article : Google Scholar : PubMed/NCBI
10	Chen J: The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med. 6:a0261042016. View Article : Google Scholar : PubMed/NCBI
11	Gulati N, Laudet B, Zohrabian VM, Murali R and Jhanwar-Uniyal M: The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res. 26:1177–1181. 2006.PubMed/NCBI
12	Metodiewa D, Jaiswal AK, Cenas N, Dickancaité E and Segura-Aguilar J: Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med. 26:107–116. 1999. View Article : Google Scholar : PubMed/NCBI
13	Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, Choudhary B and Raghavan SC: Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep. 6:240492016. View Article : Google Scholar : PubMed/NCBI
14	Qiao Y, Cao J, Xie L and Shi X: Cell growth inhibition and gene expression regulation by (−)-epigallocatechin-3-gallate in human cervical cancer cells. Arch Pharm Res. 32:1309–1315. 2009. View Article : Google Scholar : PubMed/NCBI
15	Cherry JJ, Rietz A, Malinkevich A, Liu Y, Xie M, Bartolowits M, Davisson VJ, Baleja J and Androphy EJ: Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function. PLoS One. 8:e845062013. View Article : Google Scholar : PubMed/NCBI
16	Tanigawa S, Fujii M and Hou DX: Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Biosci Biotechnol Biochem. 72:797–804. 2008. View Article : Google Scholar : PubMed/NCBI
17	Thangasamy T, Sittadjody S, Lanza-Jacoby S, Wachsberger PR, Limesand KH and Burd R: Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase. Nutr Cancer. 59:258–268. 2007. View Article : Google Scholar : PubMed/NCBI
18	Yang GY, Liao J, Kim K, Yurkow EJ and Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998. View Article : Google Scholar : PubMed/NCBI
19	Mohan S, Bustamam A, Ibrahim S, Al-Zubairi AS, Aspollah M, Abdullah R and Elhassan MM: In vitro ultramorphological assessment of apoptosis on CEMss induced by linoleic acid-rich fraction from Typhonium flagelliforme tuber. Evid Based Complement Alternat Med 2011. 4218942011.
20	Zanier K, Charbonnier S, Sidi AO, McEwen AG, Ferrario MG, Poussin-Courmontagne P, Cura V, Brimer N, Babah KO, Ansari T, et al: Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science. 339:694–698. 2013. View Article : Google Scholar : PubMed/NCBI
21	Jordan MA, Toso RJ, Thrower D and Wilson L: Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA. 90:9552–9556. 1993. View Article : Google Scholar : PubMed/NCBI
22	Hengstermann A, Linares LK, Ciechanover A, Whitaker NJ and Scheffner M: Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc Natl Acad Sci USA. 98:1218–1223. 2001. View Article : Google Scholar : PubMed/NCBI
23	Van Kriekinge G, Castellsagué X, Cibula D and Demarteau N: Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths. Vaccine. 32:733–739. 2014. View Article : Google Scholar : PubMed/NCBI
24	Peirson L, Fitzpatrick-Lewis D, Ciliska D and Warren R: Screening for cervical cancer: A systematic review and meta-analysis. Syst Rev. 2:352013. View Article : Google Scholar : PubMed/NCBI
25	Wätjen W, Michels G, Steffan B, Niering P, Chovolou Y, Kampkötter A, Tran-Thi QH, Proksch P and Kahl R: Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. J Nutr. 135:525–531. 2005. View Article : Google Scholar : PubMed/NCBI
26	Laptenko O, Beckerman R, Freulich E and Prives C: p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation. Proc Natl Acad Sci USA. 108:10385–10390. 2011. View Article : Google Scholar : PubMed/NCBI
27	Charrier-Savournin FB, Château MT, Gire V, Sedivy J, Piette J and Dulic V: p21-mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Moll Biol Cell. 15:3965–3976. 2004. View Article : Google Scholar
28	Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1799–1805. 1994.PubMed/NCBI
29	Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ and El-Deiry WS: BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol. 4:842–849. 2002. View Article : Google Scholar : PubMed/NCBI
30	Nakano K and Vousden KH: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 7:683–694. 2001. View Article : Google Scholar : PubMed/NCBI
31	Erster S, Mihara M, Kim RH, Petrenko O and Moll UM: In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. J Biol Chem. 24:6728–6741. 2004.
32	Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, Klein C, Pan H, Kessler H, Pancoska P and Moll UM: WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem. 281:8600–8606. 2006. View Article : Google Scholar : PubMed/NCBI
33	Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D and Nagini S: The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol. 649:84–91. 2010. View Article : Google Scholar : PubMed/NCBI
34	Malecka KA, Fera D, Schultz DC, Hodawadekar S, Reichman M, Donover PS, Murphy ME and Marmorstein R: Identification and characterization of small molecule human papillomavirus E6 inhibitors. ACS Chem Biol. 9:1603–1612. 2014. View Article : Google Scholar : PubMed/NCBI
35	Mietz JA, Unger T, Huibregtse JM and Howley PM: The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11:5013–5020. 1992. View Article : Google Scholar : PubMed/NCBI
36	Cooper B, Schneider S, Bohl J, Jiang Yh, Beaudet A and Vande Pol S: Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology. 306:87–99. 2003. View Article : Google Scholar : PubMed/NCBI